Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00681083 · ClinicalTrials.gov registry record · NA
Titration Pressures in Sleep Apnea Patients Using ThermoSmart® Versus Conventional Humidification
A NA study of Sleep Apnea, Obstructive, sponsored by Fisher and Paykel Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 2
- Study locations
NCT00681083: Completed NA study of Sleep Apnea, Obstructive, sponsored by Fisher and Paykel Healthcare.
NCT00681083 is a NA study of Sleep Apnea, Obstructive that has completed, run by Fisher and Paykel Healthcare. The registered enrollment target is 26 participants, below the 262-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00681083, a NA study of Sleep Apnea, Obstructive, has completed, sponsored by Fisher and Paykel Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 2
- Study locations
Study Summary
Patients who have Obstructive Sleep Apnea (OSA) may have different Continuous Positive Airway Pressure (CPAP)when titrated with different levels of humidification. It is hypothesised that patients with ThermoSmart® technology (heated breathing tube technology) will have lower titrated pressures than those who are titrated using conventional humidification (non heated breathing tube).
Primary Outcome
Each night, the participant underwent a CPAP titration to determine their therapeutic pressure. During a titration, a sleep technician manually adjusts the participants pressure to determine which pressure is best for that individual in reducing their Apnea Hypopnea Index (AHI) which is the measure of Obstructive Sleep Apnea (OSA) severity. Titration pressures for each group were compared to see if there was any impact of having a heated breathing tube versus a non heated breathing tube on titra
Conditions Studied
Interventions
- DEVICE Heated breathing tube (CPAP with ThermoSmart)
- DEVICE Non heated breathing tube (CPAP with conventional humidification)
Study Locations (2)
Oklahoma
- Sleep Center of Tulsa - Midtown - Tulsa
- Sleep Center of Tulsa - South - Tulsa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-04 |
| Est. Completion | 2008-07 |
| Phase | NA |
What the finished NCT00681083 record still lists
NCT00681083 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 262-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Sleep Apnea, Obstructive appearing as the primary indexed condition, and to 2 interventions - of which Heated breathing tube (CPAP with ThermoSmart) is the first listed.
NCT00681083 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT00681083 about?
NCT00681083 is a clinical study titled "Titration Pressures in Sleep Apnea Patients Using ThermoSmart® Versus Conventional Humidification". Patients who have Obstructive Sleep Apnea (OSA) may have different Continuous Positive Airway Pressure (CPAP)when titrated with different levels of humidification. It is hypothesised that patients with ThermoSmart® technology (heated breathing tube technology) will have lower titrated pressures than...
What is the current status of trial NCT00681083?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2008-04. Estimated completion is 2008-07.
What conditions does trial NCT00681083 study?
This clinical trial studies the following conditions: Sleep Apnea, Obstructive.
What interventions are being tested in trial NCT00681083?
The interventions under investigation include: Heated breathing tube (CPAP with ThermoSmart) (DEVICE), Non heated breathing tube (CPAP with conventional humidification) (DEVICE).
Who is sponsoring clinical trial NCT00681083?
This trial is sponsored by Fisher and Paykel Healthcare, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00681083 being conducted?
This trial has 2 study locations across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Apnea, Obstructive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00681083's enrollment target sits among peer trials
26 36th of 45 higher than 9 of 45 other Sleep Apnea, Obstructive trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Apnea, Obstructive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The PREDICTOR Study: Assessing Diagnostic Predictors of Airway Collapse in Patients With Obstructive Sleep Apnea
RECRUITING · NA
-
Home Apnea Testing in CHildren Trial
RECRUITING · NA
-
Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy
RECRUITING · NA
-
The REPOSE (Reach for Equity in Pediatric Sleep Evaluation) Navigation Intervention
RECRUITING · NA
-
Type 1 Diabetes and Obstructive Sleep Apnea
RECRUITING · NA
-
NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Adult Obstructive Sleep Apnea (OSA) Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia